Physician profile
Daniel E Goldberg
NPI 1699866301
$6,210.29
in general payments reported to CMS, 2019-2025
15 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.07 · 2020: $14.25 · 2021: $179 · 2022: $69.01 · 2023: $5,553 · 2024: $195 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Travel and Lodging: $919 · Food and Beverage: $338 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Travel and Lodging | $919.43 |
| Food and Beverage | $337.78 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $5,486.59 | 2022-2025 | Simbrinza, Rocklatan |
| Cardinal Health 110 LLC | $150.00 | 2024 | |
| Novartis Pharmaceuticals Corporation | $137.88 | 2021-2023 | |
| Aerie Pharmaceuticals, INC. | $124.99 | 2021 | |
| Astellas Pharma US INC | $48.10 | 2024-2025 | Izervay |
| Ani Pharmaceuticals, INC. | $46.74 | 2024-2025 | Purified Cortrophin Gel |
| Shire North American Group INC | $41.07 | 2019 | |
| Abbvie INC. | $34.88 | 2023 | |
| Genentech USA, INC. | $30.45 | 2023-2025 | Susvimo, Vabysmo |
| Dompe US, INC. | $24.67 | 2025 | Oxervate |
| Apellis Pharmaceuticals, INC. | $24.53 | 2025 | Syfovre |
| Allergan, INC. | $17.91 | 2021 | |
| Alimera Sciences, INC. | $14.57 | 2023 | Yutiq |
| Sun Pharmaceutical Industries INC. | $14.25 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $13.66 | 2024 | Eylea Hd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.